Cooley advised underwriters on ADC Therapeutics’ $232.7 million initial public offering of 12,245,631 shares of common stock. Morgan Stanley & Co., BofA Securities, Inc. and Cowen and Company, LLC acted as joint book-running managers for the offering. ADC Therapeutics securities now trade on the New York Stock Exchange under the symbol “ADCT.” Partners Div Gupta, Rich Segal, and Alison Hagerty led the Cooley team.